Steven Davidoff Solomon writes for The New York Times, Dec. 9, 2015
Yahoo remains stuck in the deal cycle, putting off what looks like an inevitable sale for another year. Still, a year gives its chief executive, Marissa Mayer, another chance to increase a price tag on the once-great Internet company.
Steven Davidoff Solomon writes for The New York Times, Dec. 8, 2015
As an asset class and with the right fund, private equity is nigh unbeatable, well worth the fees paid.
Steven Davidoff Solomon and Eugene Kontorovich write for The Wall Street Journal, Dec. 1, 2015
The moral myopia and academic perversity of these boycotts have been widely discussed. Less well understood is that in many cases they also are illegal. Under corporate law, an organization, including a nonprofit, can do only what is permitted under the purposes specified in its charter.
Steven Davidoff Solomon writes for The New York Times, Dec. 1, 2015
House Republicans are trying to shut down the Consumer Financial Protection Bureau’s attempt to regulate the $900 billion auto finance industry. It’s a political battle that just might lead to the end of the fledgling agency’s mission to regulate every nook and cranny of consumer finance.
Steven Davidoff Solomon interviewed by Daily Journal (registration required), Nov. 19, 2015
“This is a milestone case and will set the standards of when banks are held liable and what their conduct should be,” he said.
Steven Davidoff Solomon writes for The New York Times, Nov. 14, 2015
Pfizer wants to acquire Allergan not to build a better business by bringing together the makers of Botox and Viagra, but because the move will lower its taxes.
Steven Davidoff Solomon writes for The New York Times, Nov. 10, 2015
Director pay is one area in which pay for performance may not even be the best idea. It could give directors incentive to encourage a company to take outsize risks. Since directors are usually protected from the downside and unlikely to be held liable, missteps might end up hurting shareholders.
Steven Davidoff Solomon quoted in The Recorder (registration required), Nov. 6, 2015
“He is giving plaintiffs the benefit of the doubt in almost every circumstance,” Solomon said.
Steven Davidoff Solomon writes for The New York Times, Nov. 6, 2015
Walgreens is required to make certain dispositions, but we don’t know what they are. This is arguably material information, and the failure to publicly disclose it seems to me to be skirting the line on the securities law requirements.
Steven Davidoff Solomon writes for The New York Times, Nov. 4, 2015
The same shareholders who repeatedly assert that they care about corporate governance and are for a shareholder voice do not seem to care about that voice at the initial offering stage. Perhaps this says a lot about how much shareholders value their vote, and it may be very little.